Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Ovarian epithelial cancer
Trial Type:  Prevention
Results 1-6 of 6 for your search:
Start Over
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients with Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Active
Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention
Age: 18 and over
Trial IDs: GOG-0225, NCI-2009-00595, CDR0000594600, NCT00719303
A Study to Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer Participants
Status: Active
Phase: Phase III
Type: Prevention
Age: 18 and over
Trial IDs: CR107047, NCI-2016-00410, 2015-001630-21, 39039039STM4001, NCT02555878
Surgery in Preventing Ovarian Cancer in Patients with Genetic Mutations
Status: Active
Phase: Phase II
Type: Prevention
Age: 30 to 50
Trial IDs: 2015-0814, NCI-2016-00778, NCT02760849
Weight-Based versus Standard Dose Enoxaparin in Preventing Blood Clots in High-Risk Hospitalized Patients with Cancer
Status: Active
Phase: Phase II
Type: Prevention, Supportive care
Age: 18 to 70
Trial IDs: 15-547, NCI-2016-00891, NCT02706249
Energy Balance Interventions in Increasing Physical Activity in BRCA-Positive Patients, Lynch Syndrome-Positive Patients, CLL Survivors or High-Risk Family Members
Status: Active
Phase: No phase specified
Type: Prevention
Age: 18 and over
Trial IDs: 2014-0230, NCI-2015-00095, NCT02194387
Levonorgestrel Intrauterine Device in Preventing Ovarian Cancer in Patients Undergoing Surgical Removal of the Fallopian Tubes and Ovaries
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Age: 35 to 45
Trial IDs: 15-105, NCI-2015-01254, NCT02477202
Start Over